Building A Global Pharmaceutical Traceability Foundation

•Download as PPS, PDF•

2 likes•1,416 views

Traceability of pharmaceutical products as they move through the global supply chain. Regulations, technology standards, trading partner interoperability can all be barriers for companies seeking to gain the benefits of supply chain visibility and collaboration. Join SupplyScape in reviewing the key considerations and common misconceptions about pharmaceutical traceability.

Health & Medicine Business News & Politics

Building a Global Traceability Foundation to Drive Visibility, Efficiency and Compliance Common Misconceptions and Key Considerations Robin Koh, Chief Strategy Officer, SupplyScape Corporation

Agenda ,[object Object],[object Object],[object Object],[object Object],[object Object]

Safe & Secure Supply Chain Model Safe and Secure Supply Chain Pharmaceutical Co Wholesaler Pharmacy Chain of Custody Security Transaction Security Trace Track Pedigree Individual Product Security Product Security Product Authentication ID Authentication Authentication

Drivers For Global Traceability Regulatory Compliance Product Security Global Traceability Regulatory Compliance States considering pedigree laws / rules PDMA in effect. No state activity States with pedigree laws / rules today US Pedigree Regulations In place In development Global Serialization & Codification Regulations 70% Medical Professional 18% Subscriber Global Pharma Safety Incidents Sources: Organisation for Economic Co-operation and Development 964 04 196 02 484 03 1,123 05 1,412 06 1,759 07 Product Security Source: BCBSA Survey of Blue Plans’ Anti-Fraud Programs Reimburse In-accuracy 5% Med Unnec. 36% Services Not Rendered 9% Excess Charges 35% Other (1) 2% Pharm Fraud 4% Service Over Utilization 9% Upcoded Service

Complexity of Global Serialization Proliferation of Regulatory Requirements ,[object Object],[object Object],[object Object]

Misconception #1: ‘ I Can Wait’ ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],The Plan is Nothing, but Planning is Everything Dwight D Eisenhower

Misconception #2: ‘Serialization has Limited ROI’ Least Realistic More Realistic CAPEX Packaging CAPEX ACF Program ACF Impact on Line Efficiency Additional Labor Data Monitoring CAPEX-Internal Additional Label Cost CAPEX CMO CAPEX DC Software Maintenance Recurring Benefit CAPEX - One Time Running Cost CAPEX IT Anti-Counterfeit Program #2 Patient Safety Program #1 Label Standardize Program Sales Enhancement Program #2 Anti-Counterfeit Program #1 Recall Enhancement Program Supply Chain Efficiency Program SC Visibility Program #1 Sales Enhancement Program #1 Data Reform Program Benefit Programs by Level of Effort Required and the Magnitude of Benefit Upside Potential Downside Impact

Misconception #3 ‘ Countries are Driving Towards One Standard’ ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Your Requirements vs. Available Solutions

Misconception # 4 ‘ Serial Number Lookup is an Authentication System’ ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Product Security Product Authentication ID Authentication Authentication Individual Product Security

Suggested Approach to Global Serialization Global Framework, Local Alignment ,[object Object],[object Object],[object Object],[object Object],[object Object],Define Global Strategy & Guidelines Address Local Requirements Migrate To Global Plan

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Key Takeaways

Looking Forward Business Opportunities in Supply Chain Traceability ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Next Steps Get Started on Developing a Global Traceability Foundation Contact Mary Hall today to schedule a consultation! 781.503.7462, mhall@supplyscape.com Visit SupplyScape.com to learn more www.supplyscape.com

This document summarizes a presentation on cyber security standards. It finds that while investments in security have increased organizations' security, many feel they are just keeping pace with escalating threats. There is growing concern over cyber threats and internal threats, though companies feel less prepared for internal risks. Most companies lack regular security training programs. Survey respondents viewed practices and architectures as important areas for standards to address. Overall, industry believes standards can help ensure secure manufacturing systems, despite the challenges and time involved.

Indicators workshop ces 2013

CesToronto

This document discusses different approaches to selecting performance indicators within and across community settings. It outlines styles of indicator selection such as management, strategic, consultative, and best practices. Important criteria for indicators are that they are authoritative, economical, ethical, feasible, logical, manageable, measurable, reliable, specific, timely, and valid. Different types of indicators are also discussed such as analog/continuous, digital/logical, qualitative/spatial, and ratio/rate measures. Performance indicators should relate to logic models and be carefully chosen.

Tech proresearch hybridcloud_infographic

Communication Innovators

Applied aatod presentation highlights

Richard Littlewood

The document describes the development of a strategic outcomes measurement tool for opioid dependence care. It discusses results from expert surveys that identified a need for improved and more comprehensive outcome measures. It then outlines key elements that should be measured, including treatment engagement, health status and risks, work status, and criminal activity. Metrics in these areas were validated with experts using a Delphi consensus process, which showed strong agreement that these metrics would appropriately measure outcomes in opioid dependence care.

Ellig Gpra And Use Of Performance Info April 2009

Mercatus Center

The Government Performance and Results Act of 1993 aimed to improve the availability and use of performance information in government agencies. This study found that higher quality agency performance reports, as measured by the Mercatus Center Scorecard, were correlated with more federal managers reporting the availability of outcome, output, and efficiency measures. Higher quality reports were also linked to greater reported use of performance information for resource allocation, priority-setting, and other purposes. However, the availability and use of performance measures varied depending on the type of programs agencies administered, such as those involving grants, regulation, or research.

Models & Trends in REMS Program Success

Best Practices

Given the stringent regulatory requirements in the health care industry, it is important for bio-pharmal companies to develop innovative Risk Evaluation and Mitigation Strategies (REMS) plans during the commercialization of certain products to ensure an acceptable risk-to-benefit ratio. This benchmark study published by Best Practices, LLC examines how companies develop and execute successful Risk Evaluation and Mitigation Strategies (REMS) plans for newly-approved drugs in the U.S. market. This study can help bio-pharma companies in creating successful REMS programs. Download Full Report: http://bit.ly/2aOt5Id

Demonstrating ROI for Telehealth Programs

Mid-Atlantic Telehealth Resource Center

Hernan Huwyler Corporate Compliance During the Coronavirus Pandemic

Hernan Huwyler, MBA CPA

The document discusses adjustments that can be made to a compliance program in response to the coronavirus pandemic. It provides over 30 recommendations for how a compliance officer can [1] protect employees and contractors, [2] protect the value chain, and [3] protect the future. Key actions include ensuring communication of new health and safety protocols, facilitating identification of critical staff, monitoring suppliers and contracts, and advising clients on force majeure impacts. The crisis also underscores the need for stronger business continuity planning and emergency preparedness within compliance programs.

The document discusses investing in quality and compliance programs to justify costs. It outlines how to quantify direct and indirect quality costs, examines the FDA's increasing focus on medical devices, and explores the impacts of non-compliance. Proactive quality systems can reduce costs compared to reactive systems. Good investments include dedicated CAPA resources, risk management programs, quality metrics, and harmonizing quality systems during acquisitions.

2020 Executive Summary: The Post-COVID Pharma Report by Reuters Events

MohamadMeski

Get the insights of 1365 life sciences professionals on the impact of COVID-19 and how they’re adapting. This is the executive summary of The Post-COVID Report by Reuters events, which details the findings of the survey conducted with 1365 life sciences professionals in April 2020. Omnipresence is a life sciences specific customer experience management (CXM) platform that enables next-gen customer experiences. Learn more at omnipresence.io

Transforming Pharmacovigilance Workflows with AI & Automation

Perficient, Inc.

Medical information call centers have an opportunity to transform the way they capture, code, and analyze adverse events (AEs) and product quality complaints (PQCs) with artificial intelligence (AI) and automation. The use of such innovative technology improves data quality and consistency, compliance, and operational efficiency. It helps reduce the frequency of your pharmacovigilance (PV) operations resources going home, saying, “I have more to do at the end of the day than I did when I started." Our one-hour, on-demand webinar shows you how you can use AI and automation to turbo-charge your end-to-end PV system. Use cases and demonstrations will include: Analyzing safety data Auto-coding verbatim terms to official medical dictionary terms Auto-creating an AE case in your database Converting speech to text

The State of Unifying Clinical Systems, Processes, and Stakeholder Collaboration

Veeva Systems

Best Practices for Managing Regulatory Binders Electronically

Veeva Systems

Risk Assessment for CAPA Determoination (decision)

Tarek Elneil

This document provides guidance on applying risk management principles to determine corrective and preventive action (CAPA) decisions. It defines factors for assessing risk, including severity, frequency, and detectability. Risk scores are calculated based on these factors for both product risks and compliance risks. The document provides a risk priority number matrix and guidance on CAPA decisions based on the risk assessment.

Life Sciences Infographic

NetDimensions

This document discusses the challenges of compliance in the life sciences industry. It notes that regulatory requirements for record keeping, documentation, cybersecurity, and software validation have become more stringent in recent years. Non-compliance can result in substantial fines, legal actions, stoppage of operations, loss of licenses, and delays in product launches. Compliance officers face challenges as regulators publish more information and requirements. Many compliance leaders do not believe their current monitoring and reporting systems minimize the impact of non-compliance or provide real-time information. The document promotes a compliance training and performance platform to help life sciences organizations better manage regulatory compliance.

C19: Respond, recover & reimagine the future of HCP engagement

Across Health

And Across Health responded in an agile way to the C19 disruption: we've taken important steps in optimizing the Navigator ecosystem, with over 6,000 HCP respondents since June, insightful COVID-19 questions, new Powertools, upgrades to our integrated OCE Planner Pro, the launch of a DIY “starterkit”, a new OCE capability-boosting platform (SCALA), etc. Our webinar will take you through the latest Navigator 365 insights, demo the newest Powertools, and show how the data can be used for evidence-based omnichannel HCP journey planning, orchestration, measurement - and ongoing optimization. Watch the recorded webinar on our website: https://bit.ly/2UmkvcU.

GP for Regulatory Management Product Sheet

Marco Villacorta Olano

The document discusses the Governance Portal, a software solution that helps companies strengthen risk culture and compliance. It provides an integrated platform that enables risk and control self-assessment, regulatory alerts, and communication of risk frameworks. The portal helps clients quickly execute compliance efficiently, create sustainability, and add value. It is a market-leading governance, risk, and compliance platform used by hundreds of clients worldwide.

Eisai EMEA: Laying the foundation for centralised medical information managem...

Veeva Systems

2005 2016 connect-springboard_impact_report_digital

BioPharma Strategy Advisors

Almost 440 companies have completed the CONNECT Springboard accelerator program since 2005. More than 290 alumni have raised over $1.6 billion in capital. Nearly 20 percent of alumni have undergone liquidity events such as acquisitions or IPOs. As of 2016, over 250 Springboard graduates were still actively in business, with alumni companies creating more than 6,000 jobs. The accelerator focuses on tech, life sciences and consumer products companies, helping entrepreneurs refine their pitch and commercialization strategy.

ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution

ValGenesis

Reimagine patient safety 2030 governance through a unified safety platform

Veeva Systems

This document discusses the evolution of pharmacovigilance (PV) and the need for a unified safety platform to address current challenges. It notes that PV currently focuses on compliance but lacks agility and innovation. There is also low technology maturity and high manual effort. Looking ahead to 2030, the role of safety will need to be reimagined to integrate more data sources, enhance patient involvement, and support predictive and personalized treatments. A unified safety system on a cloud platform could help by integrating data from across the product lifecycle, streamlining processes, and enabling greater collaboration.

Speed Clinical Trials from Start to Close: The Path to a Modern CTMS

Veeva Systems

Collaborate Effectively to Transform Clinical Trials

Veeva Systems

View slides from Veeva's plenary session at ExL's 8th Trial Master File Summit to: • Learn opportunities to transform trial execution through greater TMF collaboration • Explore innovative ways to enhance collaboration by automating the exchange of TMF data between sponsors, CROs, and sites • Learn how to gain and leverage continuous visibility of clinical data exchange to improve oversight, compliance, and decision-making

Measuring ROI in life sciences? Not a black & white story

Across Health

The first results of the 2021 Maturometer confirm that the ROI question is more important than ever. Join Jan Keuppens (SVP Global Accounts) and Christophe Brock (Head of Intelligent Execution & Impact) to learn the value of a solid impact measurement approach: it not only influences key decision-making, but it also contributes to a change of mindset. Key topics include: • Why strong impact measurement relies on a strong strategy and business case development o Impact measurement as key component of campaign and customer journey strategy • How your omnichannel maturity influences the type & level of KPIs o Realistic vs “vanity” KPIs • Understand the continuum between “essential” and “state-of-the-art” KPIs • Explore examples of how impact measurement influences key decision-making Watch the recorded webinar and access the full deck on our website: https://bit.ly/3felUMK

Omnichannel launch excellence in the never normal

Across Health

Like many other things, launch excellence will never be the same again post-C19… Ruud Kooi (SVP Global Accounts) and Luisa Schirm (Senior Consultant) will show you how an integrated customer-centric approach should be an essential ingredient of any launch – now, more than ever. Key topics include: · Omnichannel as the “booster shot” for post-C19 launches · The Omnichannel Launch Excellence (O.L.E.) framework explained · How to translate a global/regional customer-centric O.L.E blueprint into local strategy execution success? Watch the recorded webinar and access the full deck here: https://bit.ly/3xOkuBs

Ignite 2015 Stefan Artlich - To Each Drug Package its Own Unique Number - Is ...

Elemica

Nobel Trace and Track Project

Murat Mendi

2013 Year of Pharmaceutical Serialization - Get it Right

Michael Stewart

Pharmaceutical serialization en mass will occur in 2013 due to US and es-US regulations to track products at the item level. Michael Stewart of PharmTech Inc. shares his insight into the project Management pitfalls and allows you to use his learning curve working with top 10 pharmaceutical manufacturers, contract manufacturers and virtual manufactures to get ROI and business value in addition to compliance. Turn a perceived cost into an investment.

Track & Trace Geneva 2014

Murat Mendi

The document discusses Turkey's track and trace system for pharmaceuticals and the system implemented by Nobel Pharma. It provides an overview of the Turkish regulations, Nobel's system which tracks over 3 billion product units annually using barcodes and a centralized database. The system provides notifications at each stage of production, distribution and sale. It has provided benefits such as reduced fraud and better inventory and recall management. Lessons learned include involving all stakeholders from the start and spending more time piloting the system.

Здравоохранение в России

PwC Russia

Презентация к выступлению партнера PwC Алины Лаврентьевой, представленная 18 октября 2012 г. в рамках специальной медицинской сессии «Здравоохранение России глазами инвестора: путь для инноваций» IV Общероссийского Форума «Инфраструктурные проекты России: дорожная карта для инвестиций».

What's hot

Maetrics: The ROI of Good Quality & Compliance

Generis

2020 Executive Summary: The Post-COVID Pharma Report by Reuters Events

MohamadMeski

Transforming Pharmacovigilance Workflows with AI & Automation

Perficient, Inc.

The State of Unifying Clinical Systems, Processes, and Stakeholder Collaboration

Veeva Systems

Best Practices for Managing Regulatory Binders Electronically

Veeva Systems

Risk Assessment for CAPA Determoination (decision)

Tarek Elneil

Life Sciences Infographic

NetDimensions

C19: Respond, recover & reimagine the future of HCP engagement

Across Health

GP for Regulatory Management Product Sheet

Marco Villacorta Olano

Eisai EMEA: Laying the foundation for centralised medical information managem...

Veeva Systems

2005 2016 connect-springboard_impact_report_digital

BioPharma Strategy Advisors

ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution

ValGenesis

Reimagine patient safety 2030 governance through a unified safety platform

Veeva Systems

Speed Clinical Trials from Start to Close: The Path to a Modern CTMS

Veeva Systems

Collaborate Effectively to Transform Clinical Trials

Veeva Systems

Measuring ROI in life sciences? Not a black & white story

Across Health

Omnichannel launch excellence in the never normal

Across Health

What's hot (17)

Maetrics: The ROI of Good Quality & Compliance

2020 Executive Summary: The Post-COVID Pharma Report by Reuters Events

Transforming Pharmacovigilance Workflows with AI & Automation

The State of Unifying Clinical Systems, Processes, and Stakeholder Collaboration

Best Practices for Managing Regulatory Binders Electronically

Risk Assessment for CAPA Determoination (decision)

Life Sciences Infographic

C19: Respond, recover & reimagine the future of HCP engagement

GP for Regulatory Management Product Sheet

Eisai EMEA: Laying the foundation for centralised medical information managem...

2005 2016 connect-springboard_impact_report_digital

ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution

Reimagine patient safety 2030 governance through a unified safety platform

Speed Clinical Trials from Start to Close: The Path to a Modern CTMS

Collaborate Effectively to Transform Clinical Trials

Measuring ROI in life sciences? Not a black & white story

Omnichannel launch excellence in the never normal

Viewers also liked

Ignite 2015 Stefan Artlich - To Each Drug Package its Own Unique Number - Is ...

Elemica

Nobel Trace and Track Project

Murat Mendi

2013 Year of Pharmaceutical Serialization - Get it Right

Michael Stewart

Track & Trace Geneva 2014

Murat Mendi

Здравоохранение в России

PwC Russia

Автомобильный рынок России

PwC Russia

Case Study: Pharmaceutical Track And Trace System in Turkey

Nart Bilişim Hizmetleri - TechNarts

The document describes Turkey's Pharmaceutical Track and Trace System (ITS) which was implemented to address issues like counterfeit drugs and drug theft. The key aspects of the system include: 1) Serializing each drug unit with a unique DataMatrix code for tracking through the supply chain from manufacturer to patient. 2) Gathering data on each drug unit at each step to enable full tracking and traceability through electronic pedigrees. 3) Centralizing the system for more efficient data management compared to document-based e-pedigree systems. 4) Producing statistics on over 40,000 stakeholders and over 6.5 billion drug units tracked to date, demonstrating the system's effectiveness.

Best Practices in the Field of Serialization and Safe Supply Chain

László Árvai

Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Viewers also liked (9)

Ignite 2015 Stefan Artlich - To Each Drug Package its Own Unique Number - Is ...

Nobel Trace and Track Project

2013 Year of Pharmaceutical Serialization - Get it Right

Track & Trace Geneva 2014

Здравоохранение в России

Автомобильный рынок России

Case Study: Pharmaceutical Track And Trace System in Turkey

Best Practices in the Field of Serialization and Safe Supply Chain

Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...

Similar to Building A Global Pharmaceutical Traceability Foundation

Data Analytics for Auditors Analysis and Monitoring

Jim Kaplan CIA CFE

1) The document discusses continuous monitoring and auditing techniques using data analytics. It provides definitions and examples of continuous monitoring, auditing, and assurance. 2) Continuous monitoring involves ongoing management oversight of controls while continuous auditing involves independent testing by internal auditors. The relationship between the two is also discussed. 3) Implementing continuous monitoring and auditing can provide benefits like early detection of issues and fraud reduction but also faces challenges like obtaining the right data and tools.

Saaba reflection group 2

salif2015

The document provides an overview of the strategic management model and process. It includes the following key elements: 1) Strategy formulation which involves developing long-range plans including the mission, objectives, strategies, policies, and environmental scanning. 2) Strategy implementation which involves putting the strategy into action through programs, budgets, procedures, and evaluating internal strengths and weaknesses. 3) Environmental scanning which involves gathering external opportunities and threats as well as internal strengths and weaknesses. 4) Evaluation and control which involves monitoring performance against the mission, goals, and objectives and providing feedback to make corrections.

Data Governance And Culture

nnorthrup

Best Practices and Points to Consider for Small-Medium Bio-Pharma Companies

Covance

Small to medium sized companies face a host of unique challenges in the management of drug safety as they prepare to launch and sustain their products. Lack of clinical, safety and regulatory resources and expertise, along with inadequate technology infrastructure can create significant challenges and risks when advancing products through the life cycle. Find out how you can help your organizations overcome some common obstacles, learn from best practices and efficiently comply with global pharmacovigilance requirements.

Plan for Success Strategies to Align Reimbursement and Commercialization - OM...

April Bright

Our POV on Launch Excellence

Indegene

At Indegene, with our digital-first approach, we bring agility and innovation to your launch strategy. We enable optimization of channels, content mix and foster continuous learning by adopting an agile operating model that supports cross-functional collaboration and enables launch teams to rapidly create campaigns to address shifting customer needs. With our AI-driven launch model, from strategy to execution, we help you achieve true ‘Launch Excellence’.

Security, Compliance & Loss Prevention Part 4.pptx

Sheldon Byron

This document discusses strategies for managing failures in the supply chain. It outlines several key strategies such as risk assessment and mitigation, contingency planning, supplier relationship management, supply chain visibility, inventory management, communication, scenario planning, data analytics, continuous improvement, and cross-functional teams. Specific tips are provided, including procuring from multiple suppliers, nearshoring, strategic partnerships, layered systems, using data, end-to-end visibility, and being informed in real-time. The overall goal of failure management is to identify vulnerabilities, plan contingencies, and maintain a resilient supply chain network.

A practical approach to 3TG risk assessment and mitigation in conflict affect...

RCS Global

An international trading company implemented a 3TG due diligence program to address risks in its supply chain and meet regulatory requirements. The program included identifying high-risk areas using conflict risk maps and country lists, enhancing know-your-customer procedures for new suppliers, requiring local certification for sourced materials, and conducting independent risk assessments of a percentage of suppliers. Initial results found risks being addressed and assurance provided to company leadership, while independent assessments helped improve the program's design and implementation. The company found that due diligence takes time but is worthwhile, and more guidance is still needed for practical upstream risk assessments and audits.

Our POV on Launch Excellence

Indegene

1. Focus on delivering a strong customer experience through digital launches as digital channels are becoming more effective than field reps. Meeting customer expectations leads to increased revenue and decreased churn. 2. Digitize existing launch toolkits and adapt them to specialized launches with restricted access as the digital shift is imperative post-COVID. This provides a potential solution for impactful launches. 3. Build generic launch types to guide customized strategies considering factors like market maturity and size. Leverage cross-functional capabilities and insights to establish the best launch type.

Developing And Executing A Program For Labeling Compliance

Chris Miller

The document discusses developing a program for labeling compliance. It notes that labeling has become complex due to increasing regulations from various government bodies. An ideal solution would be one that adapts to regulatory changes and lowers risks of non-compliance. Key aspects of implementing a solution include user training, validation, label design, documentation, and supplier management. The document provides an overview of developing a holistic labeling compliance program.

Qumas Collaboration to Innovation Quality QMS PIMS 2014

GBX Summits

Creating a Business Case for Big Data

Perficient, Inc.

Although Big Data is changing enterprise data architecture models, support for Big Data extends beyond the walls of IT. The most successful companies are focused on building strong business cases for Big Data to drive support, adoption and funding though the enterprise. This webinar investigated the two perspectives in constructing a business case for Big Data as well as how to create a compelling business case for Big Data success. During this webinar, we covered: -Challenges Creating Business Cases for Big Data -Two perspectives for building Big Data business-cases -Building the business-focused case and getting to monetized benefits -Fortifying your business case with IT-benefits

Surviving The Perfect Storm Private Briefing

Nik Hasyudeen

The document outlines a 5-step process for business leaders to survive in the face of changing trends: 1) Identify trends shaping their industry; 2) Map the impact of trends on their business; 3) Consider options for how to respond; 4) Develop plans to deliver intended results from chosen options; 5) Execute plans and monitor outcomes. It then provides examples of trends, their potential impacts, and initial options and plans one company is considering to increase efficiency and reposition itself.

2016 Risk Management Workshop

Stacy Willis

The document discusses designing effective cybersecurity risk management and education programs. It provides an overview of the objectives of the workshop, which are to assess risks and gaps, understand what needs to be done to address them, and create an enterprise-level risk management program. It also discusses scenarios involving a data breach, system outage, and malware outbreak to demonstrate potential costs. The document emphasizes measuring cybersecurity maturity levels and prioritizing the highest risks and most important strategic drivers for an organization.

AGENDA CBI RBM 2019 | RISK-BASED TRIAL MANAGEMENT and MONITORING

Cyntegrity | Data Science for Clinical Trials

Will I see you in Philadelphia next week? In case you don’t already know, I’ve been invited to speak at CBI’s Risk-Based Trial Management and Monitoring Conference. I’m going to be sharing real world, pragmatic guidance that you can implement immediately to effectively influence your clinical trial performance. My presentation, Practical Usage of KRIs and QTLs in Clinical Trials, will take place next Thursday, November 14th at 9:45am. I’m going to share with you: • How to identify and close the gaps between risks and KRIs • What the difference is between KRIs and QTLs, and how to use them effectively • Useful examples of Centralized Monitoring findings from open data • How to detect, combat and prevent fraud and sloppiness at an early stage • How AI and ML advance risk-based approaches So I can’t wait to see you at this informative and fun-filled industry expert forum, – Artem Andrianov, CEO Cyntegrity

Informed Manufacturing: Reaching for New Horizons

Cognizant

Although still in its infancy, informed manufacturing -- making the right information available in the right form at the right time -- is advancing across industry sectors. Cognizant's recent in-depth study involving interviews with manufacturing CXOs, engineering firms, service and IT providers, academia and industry analysts worldwide, revealed that while most companies understand the signifiance of informed manufacturing, many are proceeding carefully -- working to balance the conflicting priorities of managing day-to-day business while focusing on innovation and breakthrough initiatives. They see external support as a critical success factor.

Survey results - Centrally vs Locally managed compliance

Nimonik

Strategic Thinking, TCF and Action Plans

Rupinder K Gill

This document discusses strategic thinking and developing action plans. It provides guidance on analyzing employee engagement survey results to select priority issues, ensuring actions are linked to business strategy and measurable. An example tracking spreadsheet is outlined for monitoring progress of actions. The document also discusses treating customers fairly principles and analyzing the internal and external environment using tools like PEST, Porter's five forces, value chain analysis and the intelligence cycle to inform strategic planning. Famous strategic thinkers like Steve Jobs and Oprah Winfrey are mentioned.

Samsung electronics case study

Service_supportAssignment

A brief Introduction to ISO 9001 2015-Quality Management System

SARWAR SALAM

Similar to Building A Global Pharmaceutical Traceability Foundation (20)

Data Analytics for Auditors Analysis and Monitoring

Saaba reflection group 2

Data Governance And Culture

Best Practices and Points to Consider for Small-Medium Bio-Pharma Companies

Plan for Success Strategies to Align Reimbursement and Commercialization - OM...

Our POV on Launch Excellence

Security, Compliance & Loss Prevention Part 4.pptx

A practical approach to 3TG risk assessment and mitigation in conflict affect...

Our POV on Launch Excellence

Developing And Executing A Program For Labeling Compliance

Qumas Collaboration to Innovation Quality QMS PIMS 2014

Creating a Business Case for Big Data

Surviving The Perfect Storm Private Briefing

2016 Risk Management Workshop

AGENDA CBI RBM 2019 | RISK-BASED TRIAL MANAGEMENT and MONITORING

Informed Manufacturing: Reaching for New Horizons

Survey results - Centrally vs Locally managed compliance

Strategic Thinking, TCF and Action Plans

Samsung electronics case study

A brief Introduction to ISO 9001 2015-Quality Management System

Recently uploaded

pathology MCQS introduction to pathology general pathology

ZayedKhan38

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes

PsychoTech Services

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

19various

Abortion PG Seminar Power point presentation

AksshayaRajanbabu

CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf

rishi2789

Ketone bodies and metabolism-biochemistry

Dhayanithi C

CBL Seminar 2024_Preliminary Program.pdf

suvadeepdas911

Cervical Disc Arthroplasty ORSI 2024.pptx

LEFLOT Jean-Louis

How to choose the best dermatologists in Indore.

Gokuldas Hospital

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

NephroTube - Dr.Gawad

- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ - Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0 - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html

June 2024 Oncology Cartoons By Dr Kanhu Charan Patro

Kanhu Charan

Travel Clinic Cardiff: Health Advice for International Travelers

NX Healthcare

Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk

Cell Therapy Expansion and Challenges in Autoimmune Disease

Health Advances

There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities. In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions. Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved. Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.

Post-Menstrual Smell- When to Suspect Vaginitis.pptx

FFragrant

Acute Gout Care & Urate Lowering Therapy .pdf

Jim Jacob Roy

Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...

Kosmoderma Academy Of Aesthetic Medicine

10 Benefits an EPCR Software should Bring to EMS Organizations

Traumasoft LLC

NARCOTICS- POLICY AND PROCEDURES FOR ITS USE

Dr. Ahana Haroon

DECLARATION OF HELSINKI - History and principles

anaghabharat01

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx

Holistified Wellness

We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.

Recently uploaded (20)

pathology MCQS introduction to pathology general pathology

Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes

Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central

Abortion PG Seminar Power point presentation

CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf

Ketone bodies and metabolism-biochemistry

CBL Seminar 2024_Preliminary Program.pdf

Cervical Disc Arthroplasty ORSI 2024.pptx

How to choose the best dermatologists in Indore.

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

June 2024 Oncology Cartoons By Dr Kanhu Charan Patro

Travel Clinic Cardiff: Health Advice for International Travelers

Cell Therapy Expansion and Challenges in Autoimmune Disease

Post-Menstrual Smell- When to Suspect Vaginitis.pptx

Acute Gout Care & Urate Lowering Therapy .pdf

Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...

10 Benefits an EPCR Software should Bring to EMS Organizations

NARCOTICS- POLICY AND PROCEDURES FOR ITS USE

DECLARATION OF HELSINKI - History and principles

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx

Building A Global Pharmaceutical Traceability Foundation

1. Building a Global Traceability Foundation to Drive Visibility, Efficiency and Compliance Common Misconceptions and Key Considerations Robin Koh, Chief Strategy Officer, SupplyScape Corporation

3. Safe & Secure Supply Chain Model Safe and Secure Supply Chain Pharmaceutical Co Wholesaler Pharmacy Chain of Custody Security Transaction Security Trace Track Pedigree Individual Product Security Product Security Product Authentication ID Authentication Authentication

4. Drivers For Global Traceability Regulatory Compliance Product Security Global Traceability Regulatory Compliance States considering pedigree laws / rules PDMA in effect. No state activity States with pedigree laws / rules today US Pedigree Regulations In place In development Global Serialization & Codification Regulations 70% Medical Professional 18% Subscriber Global Pharma Safety Incidents Sources: Organisation for Economic Co-operation and Development 964 04 196 02 484 03 1,123 05 1,412 06 1,759 07 Product Security Source: BCBSA Survey of Blue Plans’ Anti-Fraud Programs Reimburse In-accuracy 5% Med Unnec. 36% Services Not Rendered 9% Excess Charges 35% Other (1) 2% Pharm Fraud 4% Service Over Utilization 9% Upcoded Service

8. Misconception #2: ‘Serialization has Limited ROI’ Least Realistic More Realistic CAPEX Packaging CAPEX ACF Program ACF Impact on Line Efficiency Additional Labor Data Monitoring CAPEX-Internal Additional Label Cost CAPEX CMO CAPEX DC Software Maintenance Recurring Benefit CAPEX - One Time Running Cost CAPEX IT Anti-Counterfeit Program #2 Patient Safety Program #1 Label Standardize Program Sales Enhancement Program #2 Anti-Counterfeit Program #1 Recall Enhancement Program Supply Chain Efficiency Program SC Visibility Program #1 Sales Enhancement Program #1 Data Reform Program Benefit Programs by Level of Effort Required and the Magnitude of Benefit Upside Potential Downside Impact

10.

11.

12.

13.

14.

15.

16. Next Steps Get Started on Developing a Global Traceability Foundation Contact Mary Hall today to schedule a consultation! 781.503.7462, mhall@supplyscape.com Visit SupplyScape.com to learn more www.supplyscape.com

Building A Global Pharmaceutical Traceability Foundation

Recommended

Recommended

More Related Content

What's hot

What's hot (17)

Viewers also liked

Viewers also liked (9)

Similar to Building A Global Pharmaceutical Traceability Foundation

Similar to Building A Global Pharmaceutical Traceability Foundation (20)

Recently uploaded

Recently uploaded (20)

Building A Global Pharmaceutical Traceability Foundation